Capricor Therapeutics, Inc. (CAPR)
31.57
-0.40
(-1.25%)
USD |
NASDAQ |
Apr 08, 16:00
31.57
0.00 (0.00%)
After-Hours: 16:03
Capricor Therapeutics Cash from Investing (TTM) : 97.48M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 14.04M |
| Vaxart, Inc. | 16.63M |
| Allogene Therapeutics, Inc. | 95.56M |
| REGENXBIO, Inc. | -15.87M |
| Replimune Group, Inc. | 216.64M |